Department of Disease Control

Research Unit for Molecular Diagnostics

Professor Naoaki Yokoyama

Bovine piroplasmosis (bovine theileriosis and babesiosis) caused by species of genera Babesia and Theileria, is characterized by fever and anemia. The disease usually results in severe economic losses in cattle industry worldwide. However, preventive and control measures against bovine piroplasmosis have often been ineffective. With an ultimate aim of minimizing the incidence of bovine piroplasmosis, we conduct research to 1) determine the current status of bovine piroplasmosis in Japan and other endemic countries; 2) identify tick vectors transmitting bovine Theileria, and thereby establish systematic tick-control measures; 3) determine immunological responses against Theileria infection in cattle and develop vaccine; 4) clarify the mechanisms by which Babesia invades erythrocytes with the objective of vaccine development; 5) establish effective techniques and tools to analyze the genetic polymorphism in vaccine candidate antigens; and 6) develop made-to-order type subunit vaccines effective in different endemic regions. To expedite our aim of eliminating bovine piroplasmosis, we maintain a strong international collaborative network and accept postgraduate students and young postdoctoral researchers for the development of human resources in countries where bovine piroplasmosis is endemic.

Theileria parasites
Babesia parasites
Tick in Mongolia
Development of a liposome-based vaccine and conducting field trials
Epidemiological surveys (buffaloes in Thailand, cattle in Mongolia and Vietnam)

Research Unit for Advanced Preventive Medicine

Professor Shin-ichiro Kawazu

Malaria

We focus on oxidative stress responses, redox (oxidation/reduction) signals, and calcium signals in malaria protozoan cells. Living organisms adjust various physiological functions by altering the oxidation-reduction balance and calcium oscillation. We focus on “watching cells” and “imaging experiments” to understand the said systems and the roles of molecules that function in the systems, using malaria protozoa as a model organism.

Babesia

We are developing technology to manipulate genes using Babesia. So far, we have developed a foreign gene expression system (green fluorescent protein-expressing protozoa) and a gene knockout system, and we are currently trying to use live imaging to clarify the mechanism of the said protozoa’s growth and infiltration n the red cells and the vector tick.

Japanese bilharziasis

Japanese bilharziasis is a zoonotic disease that prevails in rural areas of Asian countries, and is closely related to rural health and sanitation and livestock sanitation. We conduct serum-epidemiological surveys using the newly developed ELISA protocol in regions of the Philippines where Japanese bilharziasis prevails, and conduct comprehensive epidemiological surveys including the survey on population genetics of the parasite and the search for reservoir hosts in endemic areas.

Assistant Professor Keisuke Suganuma

Trypanosomoses are endemic in many countries and affect both humans and animals. However, no effective control measures are available for this disease. We therefore aim to develop and establish effective control strategies for trypanosomoses.

Studies on developmental-stage conversion mechanisms. (Fig. 1)

Developmental-stage conversion (or cell differentiation) is essential for trypanosomes to parasitize mammalian hosts and vectors. Therefore, we aim to reveal the stage conversion mechanisms using gene manipulation technology, with the aim of developing new control strategies for trypanosomoses.

Global surveillance and establishment of new laboratory strains of trypanosomes. (Fig. 2)

We aim to establish effective control strategies for trypanosomoses in endemic countries based on field surveillance data. In addition, we intend to isolate and establish field strains of trypanosomes for further study.

Development of novel trypanocidal drugs.

We aim to find novel trypanocidal compounds by using in vitro drug screening systems and mouse models.

Fig. 1
Fig. 2

Fig. 1: GFP expressed transgenic Trypanosoma congolense (Suganuma et al., 2012 & 2013)
Fig. 2: Trypanosoma equiperdum isolated from Mongolia (IVM-t1 strain) (Suganuma et al., 2016) (Trypanosoma equiperdum)

Research Unit for Infection and Pathology

Professor Makoto Igarashi

Toxoplasmosis is a zoonotic disease latently infecting 20% to 30% of the world’s population. Toxoplasma causes serious problems in immune-suppressed people such as HIV patients and the elderly as well as in congenitally infected infants. This laboratory is working on unraveling the mechanism of Toxoplasma’s parasitism in hosts.

Main Research Project
  • Understanding Toxoplasma’s parasitism in host cells:
    We aim to identify target molecules for new medicines by isolating molecules involved in Toxoplasma’s parasitism in host cells.
  • Understanding the transition process from acute to chronic Toxoplasma infection:
    During the transition from an acute to a chronic infection Toxoplasma changes its life cycle from a propagation type to a cyst-forming type. By uncovering the mechanism of this change we aim to utilize it for vaccine development strategies.
Stage conversion Toxoplasma
Identification of the bradyzoite- specific DPA molecule and its expression in a cerebral cyst
Creation of a GRA22 gene knockout strain
Is GRA22 involved in egress from host cekks?